Journal article
Nasal High-Flow Therapy for Preterm Infants: Review of Neonatal Trial Data
BJ Manley
Clinics in Perinatology | W B SAUNDERS CO-ELSEVIER INC | Published : 2016
Abstract
Heated, humidified, nasal high-flow (HF) therapy is a promising treatment for preterm infants, and almost certainly has a place in the clinical care of this population. It is only in the last few years that data have become available from randomized trials comparing HF with other noninvasive respiratory support modes, particularly nasal continuous positive airway pressure. This article discusses the evidence for HF use from randomized clinical trials in preterm infants and proposes recommendations for evidence-based practice.
Grants
Funding Acknowledgements
B.J. Manley is an investigator on several clinical trials of nasal high-flow in newborn infants, both published and ongoing, and is a recipient of a research fellowship from the National Health and Medical Research Council (Australia). He is a coauthor of the recently published, updated Cochrane Review of nasal high-flow use in preterm infants (Wilkinson and colleagues 2016). He has no other conflicts of interest to declare.